Semaglutide and Weight Loss Medications: Beyond Diabetes and Obesity
The continuous progress in medicine has allowed semaglutide, a drug initially approved in 2017 for the treatment of type 2 diabetes, to gain greater significance by being approved in a higher dosage version and a new name, Wegovy, which was approved by the FDA on June 4, 2021. This approval from the Food and Drug […]
